Large Nosocomial Outbreak Associated with a Norwegian Scabies Index Case Undergoing TNF-α Inhibitor Treatment: Management and Control
- 19 August 2015
- journal article
- concise communications
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 36 (11), 1358-1360
- https://doi.org/10.1017/ice.2015.188
Abstract
We describe a large outbreak associated with a crusted (Norwegian) scabies case in an immunocompromised patient following treatment with TNF-α inhibitor (adalimumab) for psoriasis arthritis. The increasing use of TNF-α inhibitors should induce clinicians to consider this serious parasitic infection when evaluating skin rashes in patients receiving biologic therapies.Infect. Control Hosp. Epidemiol. 2015;36(11):1358–1360Keywords
This publication has 8 references indexed in Scilit:
- Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysisThe Lancet, 2015
- Crusted scabies complicates etanercept therapy in a patient with severe psoriasisJournal of the American Academy of Dermatology, 2013
- Rapid control of a scabies outbreak at a tertiary care hospital without ward closureAmerican Journal of Infection Control, 2012
- Factors Associated with Severe Skin Infections in Patients Treated with Biologic Therapies for Inflammatory Rheumatic DiseasesDermatology, 2012
- Scabies Outbreak in an Intensive Care Unit with 1,659 Exposed Individuals—Key Factors for Controlling the OutbreakInfection Control & Hospital Epidemiology, 2009
- Nosocomial scabiesJournal of Hospital Infection, 2007
- Crusted scabies in a patient being treated with infliximab for juvenile rheumatoid arthritisJournal of the American Academy of Dermatology, 2005
- Nosocomial Transmission and Infection Control Aspects of Parasitic and Ectoparasitic Diseases Part III. Ectoparasites/Summary and ConclusionsInfection Control & Hospital Epidemiology, 1991